Individual lifetime benefit from low-dose colchicine in patients with chronic coronary artery disease

P.M. Burger(University Medical Center Utrecht), Jeroen Schaap, Alison Morton, Deepak L. Bhatt(Brigham and Women's Hospital), Alan Whelan, Randall Hendriks, Jan H. Cornel(Brigham and Women's Hospital), Aernoud T.L. Fiolet(University Medical Center Utrecht), Xianfan Xu(Purdue University West Lafayette), I. C. D. Westendorp(Red Cross Hospital), Folkert W. Asselbergs, A. Jerzewski, Maarten J. Cramer(SUNY Downstate Health Sciences University), Driek Beelen(IJsselland Ziekenhuis), Arend Mosterd(Werkgroep Cardiologische centra Nederland), Shirley Jansen(Harry Perkins Institute of Medical Research), P.R. Nierop, P. Salkani, Martin Teraa(Maine Farmland Trust), Marjo S. van der Knaap(Amsterdam Neuroscience), Charley Budgeon(The University of Western Australia), Jannick A N Dorresteijn(Heidelberg University), Stefan M. Nidorf(Harry Perkins Institute of Medical Research), Benjamin King, Frank L.J. Visseren, Stefan Koudstaal, Fabrice M A C Martens(Deventer Ziekenhuis), Timo Lenderink, John W. Eikelboom(King's College Hospital), Anna Thompson, H. Bakker-Lohmeijer, Petra Bunschoten, Peter L. Thompson(The University of Western Australia), I.W. Tan, R Lardinois, H. Swart, Alex de Vos, B Hockings, Pieter Hoogslag, R. Kingma, Salem H.K. The, M. A. Ireland, Philip Thompson(The Heart Research Institute), Donald Latchem, S. van der Kooi, Philippe Gabríel Steg(Sorbonne Paris Cité)
European Journal of Preventive Cardiology
July 6, 2023
Cited by 16


Related Papers